Feed LGNZZ
LG
Ligand Pharmaceuticals, Inc.
LGNZZ · OTC
$0.06 +0.00% (+$0.00)
1M +0.00%
Market Cap $1.2M
P/E Ratio 0.03x
Div. Yield -
ROE 4.21%
Bulios Fair Price
$0.08
33.3% upside
Preț actual
$0.06
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile LGNZZ sunt în prezent subevaluate față de prețul lor de piață. Cum funcționează?
Valuation
100 /100
Cheap P/B 0.00x
P/E 0.03x
P/FCF 0.02x
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
49 /100
Moderate Op. margin 3.06%
Gross margin 12.42%
FCF margin 23.17%
Quality
11 /100
Poor ROA 2.43%
ROIC 0.79%
Asset turnover 0.17x
Debt
76 /100
Low Int. coverage -85.23x
Debt/Equity 0.47x
Net debt/EBITDA -11.20x
Stability
91 /100
Stable Beta 0.98x
Profitable years N/A
Rev. volatility N/A
Întreabă StockBot despre LGNZZ
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Todd C. Davis
Employees
47
Headquarters
Jupiter
Evenimente viitoare
05 NOV.
Earnings
Upcoming earnings report